Cancer Therapeutics CRC Pty Ltd

Cancer Therapeutics CRC Pty Ltd has been formed through a collaboration between a number of Australia’s leading research institutions and commercial organisations for the purposes of cancer drug discovery and development. It is funded under the Australian Government’s CRC scheme.

The objective of the Company is to take novel or relatively novel molecular targets or early stage compounds from research institutes or biotech companies in Australia, or overseas, undertake hit discovery, hit to lead development and lead optimisation, to produce high quality pre-clinical trial candidates for further development through commercialisation.